kw.\*:("DESONIDE")
Results 1 to 23 of 23
Selection :
Control of the bioavailability of a topical steroid; comparison of desonide creams 0.05% and 0.1% by vasoconstrictor studies and clinical trialsBARRY, B. W; FYRAND, O; WOODFORD, R et al.Clinical and experimental dermatology (Print). 1987, Vol 12, Num 6, pp 406-409, issn 0307-6938Article
Self-reported Participant Experience With Desonide Hydrogel in the Treatment of Mild to Moderate Atopic DermatitisKERNEY, Donna L; FORD, Rosanne O; GOTZ, Vincent et al.Cutis (New York, NY). 2011, Vol 88, Num 1S, pp 18-24, issn 0011-4162, 7 p., SUPArticle
PROBLEMS IN SELECTION OF TOPICAL ANTI-INFLAMMATORY CORTICOSTEROIDS = PROBLEMES POSES PAR LE CHOIX DES CORTICOIDES ANTIINFLAMMATOIRES LOCAUX1973; CANAD. MED. ASS. J.; CANADA; DA. 1973; VOL. 108; NO 1; PP. 33-38; ABS. FR.; BIBL. 36REF.Serial Issue
COMPARISON OF THE EFFECTS OF A NON-STEROIDAL ANTI-INFLAMMATORY AGENT, AN IMMUNOSUPPRESSIVE, A CORTICOSTEROID AND AN IMMUNOMODULATOR ON VARIOUS IMMUNOLOGICAL AND NON-IMMUNOLOGICAL INFLAMMATORY EXPERIMENTAL MODELSTARAYRE JP; LAURESSERGUES H.1980; ARCH. INTERNATION. PHARMACODYN. THERAP.; BEL; DA. 1980; VOL. 242; NO 1; PP. 159-176; BIBL. 3 P.Article
Evaluation of cross-reactivity between budesonide and desonideFOTI, C; CASSANO, N; VENA, G. A et al.Contact dermatitis. 2002, Vol 47, Num 2, pp 109-110, issn 0105-1873, 2 p.Article
COMPARISON OF THE EFFECT OF PHENYLBUTAZONE, DESONIDE AND CYCLOPHOSPHAMIDE ON FOUR TYPES OF EXPERIMENTAL PLEURISYTARAYRE JP; LAURESSERGUES H.1980; J. PHARM. PHARMACOL.; GBR; DA. 1980; VOL. 32; NO 6; PP. 408-412; BIBL. 27 REF.Article
EVALUATION DE LA DISPONIBILITE TOPIQUE DES CORTICOSTEROIDES PAR UNE METHODE PHARMACOLOGIQUERABIER REGINE.1980; ; FRA; CLERMONT-FERRAND: BLOC-SANTE; DA. 1980; 162 P.: ILL.; 30 CM; BIBL. 150 REF.; TH. UNIV.: PHARM./CLERMONT 1/1980/5 UThesis
Desonide foam 0.05% : Safety in children as young as 3 monthsHEBERT, Adelaide A.Journal of the American Academy of Dermatology. 2008, Vol 59, Num 2, pp 334-340, issn 0190-9622, 7 p.Article
Controlled, bilateral, comparative evaluation of 0.05% desonide lotion and desonide cream in eczematous dermatitisPRAWER, S. E; KATZ, H. I; HERNDON, J. H et al.Current therapeutic research. 1993, Vol 53, Num 6, pp 607-613, issn 0011-393XArticle
Potency ranking of two new topical corticosteroid creams containing 0.1% desonide or 0.05% halometasone utilising the human skin blanching assayMEYER, E; SMITH, E. W; HAIGH, J. M et al.Arzneimittel-Forschung. 1988, Vol 38, Num 12, pp 1840-1843, issn 0004-4172Article
EVALUATION OF ATROPHY PRODUCTION AND VASOCONSTRICTOR POTENCY IN HUMAN FOLLOWING INTRADERMALLY INJECTED CORTICOSTEROIDS = APPRECIATION DE L'ATROPHIE ET DE LA VASOCONSTRICTION INDUITE CHEZ L'HOMME PAR L'INJECTION DE CORTICOIDES INTRADERMIQUESSNYDER DS; GREENBERG RA.1974; J. INVEST. DERMATOL.; U.S.A.; DA. 1974; VOL. 63; NO 6; PP. 461-463; BIBL. 15REF.Article
An investigator-blind, randomized, 4-week, parallel-group, multicenter pilot study to compare the safety and efficacy of a nonsteroidal cream (Promiseb Topical Cream) and desonide cream 0.05% in the twice-daily treatment of mild to moderate seborrheic dermatitis of the faceELEWSKI, Boni.Clinics in dermatology. 2009, Vol 27, Num 6S, issn 0738-081X, S48-S53, SUP2Article
Safety and efficacy of desonide hydrogel 0.05% in pediatric subjects with atopic dermatitisHEBERT, Adelaide A; COOK-BOLDEN, Fran E; BASU, Sarmistha et al.Journal of drugs in dermatology. 2007, Vol 6, Num 2, pp 175-181, issn 1545-9616, 7 p.Article
Multicenter trial for long-term safety and efficacy comparison of 0.05% desonide and 1% hydrocortisone ointmenets in the treatment of atopic dermatitis in pediatric patientsJORIZZO, J; LEVY, M; CZERNIELEWSKI, J. M et al.Journal of the American Academy of Dermatology. 1995, Vol 33, Num 1, pp 74-77, issn 0190-9622Article
Identification and analysis of a degradation product of the glucocorticoid desonide in ointmentNGUYEN, T. T; KRINGSTAD, R; AASEN, A. J et al.Acta chemica Scandinavica. Series B. Organic chemistry and biochemistry. 1988, Vol 42, Num 6, pp 403-407, issn 0302-4369Article
CLINICAL COMPARISON OF DESONIDE CREAM WITH BETAMETHASONE VALERATE CREAM: A DOUBLE-BLIND RANDOMIZED STUDY = COMPARAISON CLINIQUE DE LA CREME AU DESONIDE AVEC LA CREME AU VALERATE DE BETAMETHASONE: UNE ETUDE A DOUBLE INSU RANDOMISEEBLUEFARB SM.1972; INTERNATION. J. DERMATOL.; U.S.A.; DA. 1972; VOL. 11; NO 2; PP. 73-76; ABS. FR. ESP.'; BIBL. 2REF.Serial Issue
Controlled evaluation of 0.05% desonide lotion and desonide cream in psoriasisGREENSPAN, A; HERNDON, J. H; BAKER, M. D et al.Current therapeutic research. 1993, Vol 53, Num 6, pp 614-620, issn 0011-393XArticle
Comparative effect of desonide cream 0.1% and 0.05% in patients with hand eczemaUGGELDAHL, P.-E; KERO, M; ULSHAGEN, K et al.Current therapeutic research. 1986, Vol 40, Num 5, pp 969-973, issn 0011-393XArticle
Etude comparative de l'efficacité et du retentissement systémique du désonide micronisé crème 0,1 p. 100 et du dipropionate de bétaméthasone crème 0,05 p. 100 dans le traitement de la dermatite atopique de l'enfant = Comparative study of efficacy and effect on plasma cortisol levels of micronised desonide cream 0.1 p. 100 versus betamethasone dipropionate cream 0.05 p. too in the treatment of childhood atopic dermatitisLEBRUN-VIGNES, B; LEGRAIN, V; AMORIC, J.-C et al.Annales de dermatologie et de vénéréologie. 2000, Vol 127, Num 6-7, pp 590-595, issn 0151-9638Article
Effect of desonide hydrogel 0.05% on the hypothalamic-pituitary-adrenal axis in pediatric subjects with moderate to severe atopic dermatitisEICHENFIELD, Lawrence F; BASU, Sarmistha; CALVARESE, Barry et al.Pediatric dermatology. 2007, Vol 24, Num 3, pp 289-295, issn 0736-8046, 7 p.Article
STEROIDS, LYSOSOMES AND DERMATITIS = STEROIDES, LYSOSOMES ET DERMATITE1972; ACTA DERMATO-VENEROL; SUEDE; DA. 1972; VOL. 52; NO 4; PP. 311-319; BIBL. 10REF.Serial Issue
A NEW METHOD FOR LABELLING 11BETA -HYDROXY STEROIDS: SYNTHESIS OF 18-2H-CORTICOSTEROIDSGREEN MJ; HO JANE SHUE; BARTNER P et al.1980; J. LABELL. COMPOUNDS RADIOPHARM.; GBR; DA. 1980; VOL. 17; NO 6; PP. 911-919; BIBL. 11 REF.Article
DEVELOPMENT OF AN HPLC ASSAY METHODOLOGY FOR A DESONIDE CREAM WITH CHEMOMETRICS ASSISTED OPTIMIZATIONLOPES, Sandra B; SARRAGUCA, J. M; PRIOR, J. A. V et al.Analytical letters. 2012, Vol 45, Num 10-12, pp 1390-1400, issn 0003-2719, 11 p.Article